Vitazi.ai

Vitazi.ai

Private
Santa Fe, New MexicoHealthcare & Life Scienceshttps://vitazi.ai

Last Round

Seed

Oct 8, 2021

Momentum Score

50 /100

Company Overview

Vitazi.ai, Inc. is a healthcare technology company that uses artificial intelligence and retinal imaging to detect early signs of chronic disease. The company's platform is designed to empower optometrists and clinicians by enabling earlier disease interception and improving patient outcomes.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Telemedicine

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

oculomicsretinal image analysisdiabetic retinopathy screeningAI medical deviceFDA cleared AIpoint-of-care diagnosticsautonomous AIsystemic disease screeningteleretinal solutionEHR integrationOculomics-as-a-ServiceCPT code reimbursementtelehealth platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vitazi.ai Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Vitazi.ai Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedOct 8, 2021

Key People

Founding team and executive leadership

Jeffrey Wigdahl

Chief Technology Officer

Executive Team

Vitazi.ai Investors

Notable investors and investment history

InvestorRounds
Tramway Venture PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 29, 2026

    Co-developing Alzheimer's detection workflow with Circular Genomics.

  • Apr 29, 2026

    Partnered with Circular Genomics for Alzheimer's disease detection.

Vitazi.ai Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vitazi.ai Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vitazi.ai's valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Fe, New Mexico
Employee Range9
Year Founded2021
Last FundingOct 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.